Developing CMC Strategies for Radiopharmaceuticals from Academia to Commercial
Time: 11:30 am
day: Conference Day Two
Details:
- Investigator INDs to Commercial INDs: Considerations for comparibility and bridging
- Developing a qTPP
- Enabling Type C Meetings for Phase 3
